Thursday, December 11, 2025 | 07:32 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Could this be the end of baldness? Scientists test breakthrough hair drug

Early trials of PP405 show it can reactivate dormant follicles and boost natural hair growth, raising hopes for a long-lasting solution to baldness

hair loss treatment, baldness cure

Early trials show PP405 can naturally restore hair growth by reactivating dormant follicles. (Photo: AdobeStock)

Barkha Mathur New Delhi

Listen to This Article

What if your bald patches could regrow hair naturally?
 
Hair loss is something that millions of people struggle with. From expensive oils to fancy shampoos and chemical solutions, most treatments only slow down the inevitable and rarely tackle the root cause. But now, scientists have found a new way to naturally boost hair density by waking up inactive follicles.
 
A new study titled Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA, published on ClinicalTrials.gov, has revealed promising results for a topical drug called PP405, developed by Pelage Pharmaceuticals. Unlike conventional options such as minoxidil or finasteride, which mainly slow hair loss, PP405 works at the root level by reactivating dormant hair follicle stem cells.
 
 
In its Phase 2a trial, participants who applied PP405 daily for eight weeks saw visible improvements, with some achieving more than a 20 per cent increase in hair density. The researchers found that the side effects were minimal, since the drug acts locally on the scalp. This breakthrough could redefine how we treat baldness and thinning hair, bringing hope for long-term, natural regrowth.

What is PP405 and how does it work?

PP405 is a topical hair regrowth drug that directly targets hair follicle stem cells. Over time, factors like ageing, stress, hormonal shifts, and environmental damage can cause these stem cells to “fall asleep,” leading to thinning or bald spots.
 
According to the researchers, PP405 reactivates these dormant cells, restoring their natural function so follicles can restart their growth cycle. This is why it doesn’t just slow hair loss—it can help hair actually grow back in previously thinning or even bald areas.

How does PP405 activate dormant hair follicles?

The study highlights that the drug helps in boosting lactate availability in the scalp. Dormant hair follicle stem cells need energy to restart their work, and lactate is that key energy source.
 
By increasing lactate levels, PP405 gives these cells the fuel they need to regenerate follicles, grow new strands, and improve scalp function. The result? Stronger circulation, healthier follicles, and long-term regrowth—going beyond the temporary volume that most treatments provide.

What did the PP405 clinical trial show?

The Phase 2a trial involved 78 adults with androgenetic alopecia (AGA), a common type of hair loss. Participants applied PP405 daily for eight weeks. The outcomes included the following:
  • 31 per cent of participants saw more than a 20 per cent increase in hair density
  • Many reported visible improvements in thickness, texture, and coverage
  • Side effects were minimal, as the drug works locally on the scalp instead of affecting the entire body
These findings make PP405 stand out as both effective and safe. A larger Phase 3 trial is planned for 2026 to confirm these benefits in a broader population.

How is PP405 different from existing hair loss treatments?

Most current treatments, whether it is minoxidil sprays, finasteride tablets, or fancy oils, focus on slowing hair shedding or improving blood flow to the scalp.
 
PP405, however, addresses the biological root cause by reactivating hair follicle stem cells. This means that instead of just holding on to existing strands, the drug can restart growth cycles and generate fresh hair.
 
That’s why dermatologists believe PP405 could redefine hair loss therapy, moving away from temporary fixes toward natural, long-lasting regrowth.

When will PP405 be available in the market?

Since PP405 is still undergoing trials, it may take five to seven years for it to pass regulatory approvals and become commercially available.
 
According to the researchers, PP405 is the first drug to show real potential for reactivating dormant follicles instead of just managing symptoms.
 
If future trials succeed, this treatment could help millions regain confidence—not through wigs, surgery, or cosmetic cover-ups, but by restoring their own natural hair. 

Since you're already here

…and clearly interested in your health, take a moment to explore our varied range of stories on wellness, medical research, and public health insights.

For more health updates, follow #HealthWithBS 
This content is for informational purposes only and is not a substitute for professional medical advice.
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 09 2025 | 12:42 PM IST

Explore News